Engineered T cells secreting αB7-H3-αCD3 bispecific engagers for enhanced anti-tumor activity against B7-H3 positive multiple myeloma: a novel therapeutic approach
2025 · Journal of Translational Medicine · 3 citations
https://doi.org/10.1186/s12967-024-05923-z